The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: Validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer

Cancer Research

Volumn 63, Issue 5, 2003, Pages 1073-1082

  Tanyi, Janos L ^a   Morris, Andrew J ^b   Wolf, Judith K ^a   Fang, Xianjun ^a   Hasegawa, Yutaka ^a   Lapushin, Ruth ^a   Auersperg, Nelly ^c   Sigal, Yury J ^b   Newman, Robert A ^a   Felix, Edward A ^a   Atkinson, Edward N ^a   Mills, Gordon B ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; HUMAN LIPID PHOSPHATE PHOSPHATASE 3; LYSOPHOSPHATIDIC ACID; MEMBRANE PROTEIN; PHOSPHATASE; SPHINGOSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYDROLYSIS; METABOLISM; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL DIVISION; ENZYME ACTIVATION; FEMALE; GENE THERAPY; HUMANS; HYDROLYSIS; LYSOPHOSPHOLIPIDS; ORGANOTHIOPHOSPHORUS COMPOUNDS; OVARIAN NEOPLASMS; PHOSPHATIDATE PHOSPHATASE; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037374562     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T., and Moolenaar, W. H. Lysophophatide-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell, 59: 45-54, 1989.
2. Koh, J. S., Lieberthal, W., Heydrick, S., and Levine, J. S. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatydilinositol 3-kinase signaling pathway. J. Clin. Investig., 102: 716-727, 1998.
3. An, S., Goetzl, E. J., and Lee, H. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J. Cell. Biochem., 30/31: 147-157, 1998.
4. Chun, J. Lysophopholipid receptors: implications for neural signaling. Crit. Rev. Neurobiol., 13: 151-168, 1999.
5. Fang, X. J., Gaudette, D., Furui, T., Mao, M., Estrella, V., Eder, A., Pustilnik, T., Sasagawa, T., Lapushin, R., Yu, S., Jaffe, R., Wiener, J., Erickson, J., and Mills, G. B. Lysophospholipid growth factors in the initiation, progression, metastases and management of ovarian cancer. Ann. N. Y. Acad. Sci., 95: 188-208, 2000.
6. Goetzl, E. J., Dolezalova, H., Kong, Y., Hu, Y. L., Jaffe, R. B., Kalli, K. R., and Conover, C. A. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res., 59: 5370-5375, 1999.
7. Xiao, Y. J., Schwartz, B., Washington, M., Kennedy, A., Webster, K., Belinson, J., and Xu, Y. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant versus nonmalignant ascitic fluids. Anal. Biochem., 290: 302-313, 2001.
8. Xu, Y., Gaudette, D. C., Boynton, J., Frankel, A., Fang, X. J., Sharma, A., Hurteau, J., Casey, G., Goodbody, A., Mellors, A., Holub, B. J., and Mills, G. B. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res., 1: 1223-1232, 1995.
9. Van Corven, E. J., Van Rijswijk, A., Jalink, K., van Der Bend, R. L., van Blitterswijk, W. J., and Moolenaar, W. H. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Biochem. J., 281: 163-169, 1992.
10. Imamura, F., Horai, T., Mukai, M., Shinkai, K., Sawada, M., and Akedo. H. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun., 193: 497-503, 1993.
11. Moolenaar, W. H., Kranenburg, O., Postma, F., and Zondag, G. C. Lysophosphatidic acid: G protein signaling and cellular responses. Curr. Opin. Cell. Biol., 9: 168-173, 1997.
12. Mills, G. B., May, C., McGill, M., Roifman, C., and Mellors. A. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. Cancer Res., 48: 1066-1071, 1988.
13. Eder, A. M., Sasagawa, T., Mao, M., Aoki, J., and Mills, G. B. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin. Cancer Res., 6: 2482-2491, 2000.
14. Okita, M., Gaudette, D. C., Mills, G. B., and Holub, B. J. Elevated levels of plasma lysophosphatidylcholine (LysoPC) in ovarian cancer patients. Int. J. Cancer, 71: 31-34, 1997.
15. Xu, Y., Shen, Z., Wiper, D. W., Wu, M., Morton, R. E., Elson, P., Kennedy, A. W., Belinson, J., Markman, M., and Casey, G. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. J. Am. Med. Assoc., 280: 719-723, 1998.
16. An, S., Dickens, M. A., Bleu, T., Hallmark, O. G., and Goetzl, E. J. Molecular cloning of human Edg 2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem. Biophys. Res. Commun., 231: 619-622, 1997.
17. An, S., Bleu, T., Hallmark, O. G., and Goetzl, E. J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem., 273: 7906-7910, 1998.
18. Bandoh, K., Aoki, J., Hosono, H., Kobayashi, S., Kobayashi, T., Murakami-Murofushi, K., Tsujimoto, M., Arai, H., and Inoue, K. Molecular cloning and characterization of a novel human G protein-coupled receptor, Edg 7, for lysophosphatidic acid. J. Biol. Chem., 274: 1-10, 1999.
19. Fang, X., Schummer, M., Mao, M., Yu, S., Tabassam, F. H., Swaby, R., Hasegawa, Y., Tanyi, J., LaPushin, R., Eder, A., Jaffe, R., Erickson, J., and Mills, G. B. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim. Biophys. Acta, 1582: 257-264, 2002.
20. Goetzl, E. J., and An, S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and spingosine 1-phosphate. FASEB J., 12: 1589-1598, 1998.
21. Furui, T., LaPushin, R., Mao, M., Khan, H., Watt, S. R., Watt, M. A., Lu, Y., Fang, X., Tsutsui, S., Siddik, Z. H., Bast, R. C., and Mills, G. B. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin. Cancer Res., 5: 4308-4318, 1999.
22. Pustilnik, T. B., Estrella, V., Wiener, J., Mao, M., Eder, A., Watt, M. A. V., Bast, R. C., and Mills, G. B. Lysophosphatidic acid induces urokinase secretion in ovarian cancer cells. Clin. Cancer Res., 5: 3704-3710, 1999.
23. Hu, Y. L., Tee, M. K., Goetzl, E. J., Auersperg, N., Mills, G. B., Ferrara, N., and Jaffe, R. B. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J. Natl. Cancer Inst. (Bethesda). 93: 762-768, 2001.
24. Waggoner, D. W., Gomez-Munoz, A., Dewald, J., and Brindley, D. N. Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatide and sphingosine 1-phosphate. J. Biol. Chem., 271: 16506-16509, 1996.
25. Xu, J., Love, L. M., Singh, I., Zhang, Q. X., Dewald, J., Wang. D. A., Fischer, D. J., Tigyi, G., Berthiaume, L. G., Waggoner, D. W., and Brindley, D. N. Lipid phosphate phosphatase-1 and Ca2+ control lysophosphatide signaling through EDG-2 receptors. J. Biol. Chem., 275: 27520-27530, 2000.
26. Waggoner, D. W., Martin, A., Dewald, J., Gomez-Munoz, A., and Brindley, D. N. Purification and characterization of novel plasma membrane phosphatidate phosphohydrolase from rat liver. J. Biol. Chem., 270: 19422-19429, 1995.
27. Imai, A., Furui, T., Tamaya, T., and Mills, G. B. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells. J. Clin. Endocr. Metab., 85: 3370-3375, 2000.
28. Pilquil, C., Singh, I., Zhang, Q., Ling, Z., Buri, K., Stromberg, L. M., Dewald, J., and Brindley, D. N. Lipid phosphate phosphatase-1 dephosphorylates exogenous lysophosphatidate and thereby attenuates its effects on cell signaling. Prostaglandins, 64: 83-92, 2001.
29. Alderton, F., Darroch, P., Sambi, B., McKie, A., Ahmed, I. S., Pyne, N., and Pyne, S. G.-protein-coupled receptor stimulation of the p42/p44 mitogen-activated protein kinase pathway is attenuated by lipid phosphate phosphatases 1, 1a and 2 in human embryonic kidney 293 cells. J. Biol. Chem., 276: 13452-13460, 2001.
30. Hooks, S. B., Santos, W. L., Im, D. S., Heise, C. E., Macdonalds, T. L., and Lynch, K. R. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent. J. Biol. Chem., 276: 4611-4621, 2001.
31. Roberts, R., Sciorra, V. A., and Morris, A. J. Substrate specificity of the human type 2a, 2b and 2c and cell surface activity of the 2a isoform. J. Biol. Chem., 273: 22059-22067, 1998.
32. Maines-Bandiera, S. L., and Auersperg, N. S. V.40 transformed ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am. J. Obst. Gyn., 167: 729-735, 1992.
33. Yu, D., Wolf, J. K., Scanlon, M., Price, J. E., and Hung, M. C. Enhanced c-erb-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by EIA. Cancer Res., 53: 891-898, 1993.
34. Roberts, R. Z., and Morris, A. J. Role of phosphatidic acid phosphatase 2a in uptake of extracellular lipid phosphate mediators. Biochim. Biophys, Acta, 1487: 33-49, 2000.
35. Sciorra, V. A., and Morris, A. J. Sequential actions of phospholipase D and phosphatidic acid phosphohydrolase 2b generate diglyceride in mammalian cells. Mol. Biol. Cell., 10: 3863-3876, 1999.
36. Hammond, S. M., Jenco, J. M., Nakashima, S., Cadwallader, K., Gu, Q., Cook, S., Nozawa, Y., Prestwich, G. D., Frohman, M. A., and Morris, A. J. Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-α. J. Biol. Chem., 272: 3860-3868, 1997.
37. Pang, S. Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene. Cancer Gene Ther., 7: 991-996, 2000.
38. Tanyi, J., LaPushin, R., Eder, A., Auersperg, N., Tabassam, F. H., Roth, J. A., Gu, J., Fang, B., Mills, G. B., and Wolf, J. Identification of tissue and cancer selective promoters for the introduction of genes into human ovarian cancer cells. Gynecol. Oncol., 85: 451-458, 2002.
39. Shen, Z., Belinson, J., Morton, R. E., Xu, J., and Xu, J. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells. Gynecol. Oncol., 71: 364-368, 1998.
40. Yutaka, H., Erickson, J. R., Lapushin, R., Mao, M., Eder, A., Tanyi, J., Aoki, J., Bandoh, K., Fang, X., and Mills, G. B. A selective EDG7 receptor subtype agonist, 1-Oleoyl-Sn-2-O-Methyl-Rac-Glycero-3-Phosphothionate (OMPT) stimulates the human ovarian cancer cell line OVCAR3. Proc. Am. Assoc. Cancer Res., 42: 188, 2001.
41. American Cancer Society. Cancer facts and figures - 2001. American Cancer Society, Inc.: Atlanta, GA, 2001.
42. Erickson, J. R., Hasegawa, Y., Fang, X., Eder, A., Mao, M., Furui, T., Aoki, J., Morris, A. J., and Mills, G. B. Lysophosphatidic acid and ovarian cancer: a paradigm for tumorigenesis and patient management. Prostaglandins, 64: 63-81, 2001.
43. Brindley, D. N. (ed.). Phosphatide Phosphohydrolase, Vol. 1, pp. 1-77. Boca Raton, FL: CRC Press, Inc., 1988.
44. Jamal, Z., Martin, A., Gomez-Munoz, A., and Brindley, D. N. Plasma membrane fraction from rat liver contain a phosphatide phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol. J. Biol. Chem., 266: 2988-2996, 1991.
45. Heise, C. E., Santos, W. L., Schreihofer, A. M., Heasley, B. H., Mukhin, Y. V., Macdonald, T. L., and Lynch, K. R. Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA I/LPA3 receptor agonist. Mol. Pharmacol., 60: 1173-1180, 2001.